Active	Status	Sponsor type	Region	Phase	Filter
14 Active 2 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KAMAR, Nassim
GOOD-IDES-02, NCT05679401: A Study With Imlifidase in Anti-GBM Disease	Active, not recruiting	3	50	Europe, US, RoW	Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids	Hansa Biopharma AB	Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome	06/25	11/26
IMAGINE, NCT03744910 / 2018-003682-34: Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients	Terminated	3	194	Europe, Canada, US, RoW	Clazakizumab, Physiologic saline solution	CSL Behring, ICON Clinical Research	Antibody-mediated Rejection	04/24	04/24
VARVARA, NCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients At Risk for Delayed Graft Function	Recruiting	2	102	Europe, Canada, US, RoW	ARGX-117, Placebo	argenx	Delayed Graft Function	04/26	12/26
TAK-620-5010, NCT06615921: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection	Recruiting	N/A	150	Europe, RoW	No Intervention	Takeda	Cytomegalovirus (CMV)	04/25	04/25
Juliette, MAZEREEUW-HAUTIER
No trials found